Corticosteroid in Dengue Hemorrhagic Fever as Preventive Treatment of Severe Outcome: A Case Report
International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 4 | Views: 376 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Case Studies | Medicine Science | Indonesia | Volume 11 Issue 2, February 2022 | Popularity: 4.5 / 10


     

Corticosteroid in Dengue Hemorrhagic Fever as Preventive Treatment of Severe Outcome: A Case Report

Nyoman Angga Santosa, Diah Pradnya Paramita, Made Wirama Diyana


Abstract: Dengue is known as the most common vector-borne viral infection between humans by Aedes genusmosquito. Dengue has a broad spectrum of disease, ranging from asymptomatic infection to a severe systemic plasma leakage syndrome. Pathogenesis of severe dengue stillpoorly understood, one factor that is thought to cause the dreaded shock syndrome is antibody-dependent enhancement. Despite of fluid replacement therapy as the main treatment, corticosteroids usage in order to suppress immune-mediated mechanisms in DHF also expected to prevent severe outcome. Since this is still controversial, further research is still very much needed.


Keywords: dengue hemorrhagic fever, dengue shock, corticosteroids, preventive treatment


Edition: Volume 11 Issue 2, February 2022


Pages: 1242 - 1245


DOI: https://www.doi.org/10.21275/SR22227092343


Please Disable the Pop-Up Blocker of Web Browser

Verification Code will appear in 2 Seconds ... Wait



Text copied to Clipboard!
Nyoman Angga Santosa, Diah Pradnya Paramita, Made Wirama Diyana, "Corticosteroid in Dengue Hemorrhagic Fever as Preventive Treatment of Severe Outcome: A Case Report", International Journal of Science and Research (IJSR), Volume 11 Issue 2, February 2022, pp. 1242-1245, https://www.ijsr.net/getabstract.php?paperid=SR22227092343, DOI: https://www.doi.org/10.21275/SR22227092343

Top